Advances in coronary stent technology--active drug-loaded stent surfaces for prevention of restenosis and improvement of biocompatibility.

Abstract:

:Beyond their originally sole mechanical function, current drug-eluting stents (DES) implement the concept of local drug delivery for the re-opening of stenotic arterial vessels, and for prevention of in-stent restenosis as one of the major limitations of conventional bare metal stents (BMS). Current DES consist of a permanent metallic stent platform and an active agent being released from a drug-incorporated polymer coating or a porous stent surface. Although DES have impressively demonstrated their capability of reducing in-stent restenosis, their safety remains under debate due to potential risks, such as delayed healing, late thrombosis and hypersensitivity demanding further development. Current advancements in the stent design address the stent platform, the pharmacologically active substance and/or the drug carrier. For instance, novel biocompatible absorbable stent platforms and drug carriers are developed and novel drugs with a differential effect on vascular endothelial and smooth muscle cells, providing efficient inhibition of muscle cells without altering the endothelial cell function, are identified. Moreover, biofunctionalization of the stent's surface with capture molecules for endothelial progenitor cells are under investigation in order to achieve an in situ endothelialization of the implant. In this context, this review paper discusses the current advances in coronary stent technology with a special focus on novel stent platforms, drugs and stent coatings for the prevention of restenosis and improvement of biocompatibility.

journal_name

Curr Pharm Biotechnol

authors

Sternberg K,Grabow N,Petersen S,Weitschies W,Harder C,Ince H,Kroemer HK,Schmitz KP

subject

Has Abstract

pub_date

2013-01-01 00:00:00

pages

76-90

issue

1

eissn

1389-2010

issn

1873-4316

pii

CPB-EPUB-20121019-8

journal_volume

14

pub_type

杂志文章,评审
  • Nutraceuticals--an emerging era in the treatment and prevention of cardiovascular diseases.

    abstract::Foods and nutrients play a vital role in normal functioning of the body. They are helpful in maintaining the health of the individual and in reducing the risk of various diseases. Worldwide acceptance of this fact formed a recognition link between "nutrition" and "health" and the concept of "nutraceuticals" was evolve...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920106775789647

    authors: Ramaa CS,Shirode AR,Mundada AS,Kadam VJ

    更新日期:2006-02-01 00:00:00

  • Oligonucleotide mediated gene targeting in mammalian cells.

    abstract::Gene targeting can be loosely defined as a process through which a specific chromosomal sequence is recognized and bound by a reagent designed for the purpose. The endpoint may be modulation of events at the target, such as transcription, or a permanent change in sequence at the site. A facile strategy for mammalian c...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/1389201043376625

    authors: Seidman MM

    更新日期:2004-10-01 00:00:00

  • Evaluation of Strategies for Decreasing Blood Glucose Using Albuminbinding Domain.

    abstract:OBJECTIVE:Frequent administrations for DPPIV-resistant GLP-1 analogs are necessary to maintain the blood concentrations due to the short half-life of less than 5 minutes. However, most delivery systems that possess the ability of sustainable release of GLP-1 have drawbacks such as low yield, high cost and undesirable s...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/1389201021666200101105018

    authors: Fan L,Fan Y,Fan H,Huang K

    更新日期:2020-01-01 00:00:00

  • Pharmacotherapy of schizophrenic patients: achievements, unsolved needs, future research necessities.

    abstract::Schizophrenia is a severe mental disorder, characterized by a complex symptomatology and a chronic relapsing course, leading to a more or less intensive residual syndrome. The disorder has strong consequences on social functioning and on the patients' quality of life and is associated with a huge economical burden for...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920112800784907

    authors: Moller HJ

    更新日期:2012-06-01 00:00:00

  • Use of transgenic mouse models to understand the origins of familial pulmonary fibrosis.

    abstract::Pulmonary fibrosis is an unremitting degenerative lung disease that has an associated high mortality. The major pathological features include the growth of fibroblasts, emergence of myofibroblasts and their production of extracellular matrix that distorts the peripheral lung tissue and impairs respiratory function. Ef...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920111798281045

    authors: Glasser SW,Senft AP

    更新日期:2011-09-01 00:00:00

  • 18F-labeled proteins.

    abstract::Positron emission tomography (PET) is a powerful and rapidly developing area of molecular imaging that is used to study and visualize human physiology by the detection of positron-emitting radiopharmaceuticals. Information about metabolism, receptor/enzyme function, and biochemical mechanisms in living tissue can be o...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920110792246564

    authors: Wu Z,Kandeel F

    更新日期:2010-09-01 00:00:00

  • LXR-agonists regulate ApoM expression differentially in liver and intestine.

    abstract::Apolipoprotein M (apoM) has been suggested to play a role in reverse cholesterol transport. Here we studied the influence of liver X-receptor (LXR) agonist on the transcriptional regulation of apoM. Studies were performed in murine liver and intestinal mucosal cells in vivo and in human intestinal Caco-2 cells in vitr...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/138920108786786376

    authors: Calayir E,Becker TM,Kratzer A,Ebner B,Panzenböck U,Stefujl J,Kostner GM

    更新日期:2008-12-01 00:00:00

  • Dual energy CT for monitoring targeted therapies in patients with advanced gastrointestinal stromal tumor: initial results.

    abstract:PURPOSE:Advanced gastrointestinal stromal tumours (GISTs) are treated with tyrosine kinase inhibitors, which also have antiangiogenic properties. Dual-energy CT (DECT) allows to acquire semi-quantitative iodine images which might correlate with blood pool and tumor vascularity. In this feasibility-study, we correlated ...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/138920111795164066

    authors: Schramm N,Schlemmer M,Englhart E,Hittinger M,Becker C,Reiser M,Berger F

    更新日期:2011-04-01 00:00:00

  • Application of Serial Analysis of Gene Expression in cancer research.

    abstract::It is now widely believed that tumors originate from normal cells as a result of accumulated genetic/epigenetic changes. These alterations affect the signaling pathways at transcriptional and post-transcriptional level that drive cells into uncontrolled cell division, growth, and migration. Recent advancement of molec...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920108785915102

    authors: Yamashita T,Honda M,Kaneko S

    更新日期:2008-10-01 00:00:00

  • IgG aggregate removal by charged-hydrophobic mixed mode chromatography.

    abstract::Charged-hydrophobic mixed mode chromatography methods have been applied to antibody purification for decades and have focused more recently on the specific task of aggregate removal. They exploit various combinations of alkyl and aromatic hydrophobic groups with positively and/or negatively charged residues. Charge an...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920109788488888

    authors: Gagnon P

    更新日期:2009-06-01 00:00:00

  • Identification and Molecular Docking Studies of Bioactive Principles from Alphonsea madraspatana Bedd. against Uropathogens.

    abstract:AIMS:The present study aims to determine the antimicrobial efficacy of Alphonsea madraspatana leaves extract against selected uropathogens. BACKGROUND:The plant Alphonsea madraspatana is an endangered species, reported to exhibit high antimicrobial activity due to the presence of phenolic compounds. Prevalence of high...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/1389201021666200107114846

    authors: Sahu A,Ghosh G,Rath G

    更新日期:2020-01-01 00:00:00

  • Use of lactobacilli and their pheromone-based regulatory mechanism in gene expression and drug delivery.

    abstract::Lactobacilli are common microorganisms in diverse vegetables and meat products and several of these are also indigenous inhabitants in the gastro-intestinal (GI) tract of humans and animals where they are believed to have health promoting effects on the host. One of the highly appreciated probiotic effects is their ab...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920109787048571

    authors: Diep DB,Mathiesen G,Eijsink VG,Nes IF

    更新日期:2009-01-01 00:00:00

  • Hydrolyzates of silkworm pupae (Bombyx mori) protein is a new source of angiotensin I-converting enzyme inhibitory peptides (ACEIP).

    abstract::Silkworm pupae protein is a good source of high quality protein. The hydrolyzates of silkworm pupae protein catalyzed by neutrase, pepsin, acidic protease (Asperqiius usamii NO. 537), flavourzyme, alcalase, and trypsin with inhibitory activity on angiotensin I-converting enzyme (ACE) were identified by HPLC. The hydro...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/138920108785161578

    authors: Wang W,Shen S,Chen Q,Tanga B,He G,Ruan H,Das UN

    更新日期:2008-08-01 00:00:00

  • Statins in the treatment of acute ischemic stroke.

    abstract::3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (also known as statins) are drugs active in the blockade of cholesterol synthesis and thus lowering cholesterol serum levels. Since their discovery, experimental evidence showed that statins strongly reduced atherogenesis and the risk of acute ischem...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920112798868737

    authors: Montecucco F,Quercioli A,Mirabelli-Badenier M,Viviani GL,Mach F

    更新日期:2012-01-01 00:00:00

  • Peroxisome proliferator activated receptor α ligands as anticancer drugs targeting mitochondrial metabolism.

    abstract::Tumor cells show metabolic features distinctive from normal tissues, with characteristically enhanced aerobic glycolysis, glutaminolysis and lipid synthesis. Peroxisome proliferator activated receptor α (PPAR α) is activated by nutrients (fatty acids and their derivatives) and influences these metabolic pathways actin...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/1389201011314030009

    authors: Grabacka M,Pierzchalska M,Reiss K

    更新日期:2013-01-01 00:00:00

  • The therapeutic potential of fungal ribotoxins.

    abstract::Ribotoxins constitute a family of toxic extracellular fungal RNases that exert a highly specific activity on a conserved region of the larger molecule of rRNA, known as the sarcin-ricin loop. This cleavage of a single phosphodiester bond inactivates the ribosome and leads to protein synthesis inhibition and cell death...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920108784567335

    authors: Carreras-Sangrà N,Alvarez-García E,Herrero-Galán E,Tomé J,Lacadena J,Alegre-Cebollada J,Oñaderra M,Gavilanes JG,Martínez-Del-Pozo A

    更新日期:2008-06-01 00:00:00

  • Adulteration Practices of Psychoactive Illicit Drugs: An Updated Review.

    abstract:BACKGROUND:Powdery drugs such as cocaine and heroin are frequently adulterated or diluted predominantly to obtain more doses and to increase the drug dealer's profits, but also to enhance, to modify or to oppose drug effects. The aim of this report is to provide an overview of the recent scientific literature on medici...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/1389201018666170710184531

    authors: Solimini R,Rotolo MC,Pellegrini M,Minutillo A,Pacifici R,Busardò FP,Zaami S

    更新日期:2017-01-01 00:00:00

  • Single-cell quantitative analysis of DNA incorporation and protein expression in microwells.

    abstract::Conventional biochemical assays are performed via an averaging procedure with the lysate of a large number of target cells; however, the averaged data lose information regarding the heterogeneity of individual cells. For quantitative assay of single cells, it is necessary to isolate single cells, extract cellular comp...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/138920110790725393

    authors: Sasaki A,Sakata H,Kinjo M

    更新日期:2010-01-01 00:00:00

  • Luteolin inhibits smooth muscle cell migration and proliferation by attenuating the production of Nox4, p-Akt and VEGF in endothelial cells.

    abstract:OBJECTIVE:The goals of this study were to observe how luteolin protects endothelial cells (ECs) from injury stimulated by Angiotensin II (Ang II), investigate the role of vascular endothelial dysfunction in vascular smooth muscle cell proliferation and migration in vitro and investigate its primary mechanism of action....

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/1389201015666140113113843

    authors: Ding H,Li D,Zhang Y,Zhang T,Zhu H,Xu T,Luo Y,Wang C

    更新日期:2014-01-01 00:00:00

  • RNA base damage and repair.

    abstract::Elaborate repair pathways counteract the deleterious effects of DNA damage by mechanisms that are understood in reasonable detail. In contrast, repair of damaged RNA has not been widely explored. This may be because aberrant RNAs are generally assumed to be degraded rather than repaired. The reason for this view is we...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920107783018363

    authors: Feyzi E,Sundheim O,Westbye MP,Aas PA,Vågbø CB,Otterlei M,Slupphaug G,Krokan HE

    更新日期:2007-12-01 00:00:00

  • Immunotherapy Approaches in Cancer Treatment.

    abstract::Tumor immune surveillance paradigm presumes that most pre-malignant cells or early malignant lesions can be eliminated (or at least controlled) by cells of the immune system. A critical feature that distinguishes advanced tumors from early neoplastic lesions is their capability to evade immune control. As a consequenc...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/1389201016666150619114554

    authors: Klener P Jr,Otáhal P,Lateckova L,Klener P

    更新日期:2015-01-01 00:00:00

  • Inhibitory Mechanisms of CME-1, a Novel Polysaccharide from the Mycelia of Cordyceps sinensis, in Platelet Activation.

    abstract::Objective: CME-1 is a polysaccharide purified from the mycelia of medicinal mushroom Cordyceps sinensis, its molecular weight was determined to be 27.6 kDa by using nuclear magnetic resonance and gas chromatography-mass spectrometry. The initiation of arterial thromboses is relevant to various cardiovascular diseases ...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:

    authors: Chang YI,Hsu WH,Lu WJ,Jayakumar T,Liao JC,Lin MJ,Wang SH,Geraldine P,Lin KH,Sheu JR

    更新日期:2015-03-03 00:00:00

  • Gallic Acid Protects from Acute Multiorgan Injury Induced by Lipopolysaccharide and D-galactosamine.

    abstract:BACKGROUND:Secondary metabolites of plants, the polyphenols, play a vital role in protection from many health problems in human beings. Structurally favored phytochemicals may be studied to protect multiorgan injury. At pharmacological doses, gallic acid is nontoxic to mammals and is generally absorbed in the intestine...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/1389201021666200615165732

    authors: Rakshit S,Nirala SK,Bhadauria M

    更新日期:2020-01-01 00:00:00

  • The Use of Biomarkers in Sepsis: A Systematic Review.

    abstract:BACKGROUND:Despite the extended laboratory and clinical study of sepsis, its diagnosis remains a clinical challenge. The initiation of sepsis activates many different biochemical and immunological pathways being expressed by alterations of various molecules in human tissues. The detection and measurement of the concent...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/1389201018666170601080111

    authors: Giannakopoulos K,Hoffmann U,Ansari U,Bertsch T,Borggrefe M,Akin I,Behnes M

    更新日期:2017-01-01 00:00:00

  • Synthesis, Characterization and Applications of Spinel Cobaltite Nanomaterials.

    abstract:BACKGROUND:Recently, spinel structures (AB2O4) nanoparticles (NPs) having binary and ternary mixtures of metal oxides were established as promising redox catalysts. Due to the presence of two mixed valence metal cations transport of electrons takes place easily between multiple transition-metal cations with relatively ...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/1389201021666201117122002

    authors: Patel AR,Sereda G,Banerjee S

    更新日期:2020-11-17 00:00:00

  • Determination of Water Content in Dehydrated Mammalian Cells Using Terahertz Pulsed Imaging: A Feasibility Study.

    abstract::Mammalian cells are involved in a range of biotechnological applications and more recently have been increasingly exploited in regenerative medicine. Critical to successful applications involving mammalian cells are their long-term storage and transport, for which cryopreservation in liquid nitrogen is the most freque...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/1389201017666151029105941

    authors: Chau DY,Dennis AR,Lin H,Zeitler JA,Tunnacliffe A

    更新日期:2015-01-01 00:00:00

  • Characterization of protein higher order structure using vibrational circular dichroism spectroscopy.

    abstract::Better understanding of protein higher order structures (HOS) is of major interest to researchers in the field of biotechnology and biopharmaceutics. Monitoring a protein's HOS is crucial towards understanding the impact of molecular conformation on the biotechnological application. In addition, maintaining the HOS is...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章

    doi:10.2174/1389201011314020010

    authors: Nagarkar RP,Murphy BM,Yu X,Manning MC,Al-Azzam WA

    更新日期:2013-01-01 00:00:00

  • Targeting the tumor stroma in cancer therapy.

    abstract::Increasing evidence shows that the interaction between neoplastic cells and the surrounding stroma is a critical factor in solid tumor growth. The tumor stroma is made up of diverse cellular populations including macrophages, lymphocytes, vascular cells, and carcinoma-associated fibroblasts. The complex interactions b...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/138920109787315088

    authors: Anton K,Glod J

    更新日期:2009-02-01 00:00:00

  • Opioid Substitution Therapy: Achieving Harm Reduction While Searching for a Prophylactic Solution.

    abstract:: ...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 社论

    doi:10.2174/138920102003190422150527

    authors: Blum K,Baron D

    更新日期:2019-01-01 00:00:00

  • Bifunctional penicillin-binding proteins: focus on the glycosyltransferase domain and its specific inhibitor moenomycin.

    abstract::Beta-lactams and glycopeptides antibiotics directed against enzymes involved in bacterial cell wall synthesis have generated bacterial resistance. Search for new antibiotic molecules is widely focused on bifunctional Penicillin-Binding Proteins (PBPs), with particular emphasis on their glycosyltransferase activity. Th...

    journal_title:Current pharmaceutical biotechnology

    pub_type: 杂志文章,评审

    doi:10.2174/1389201023378436

    authors: Di Guilmi AM,Dessen A,Dideberg O,Vernet T

    更新日期:2002-06-01 00:00:00